

Czech Republic and Slovakia had their own websites which is provided information about desensitisation.
The European bio-pharmaceutical company Stallergenes announces the launch of its new websites in Czech Republic and Slovakia.
Stallergenes, present in these countries for more than 10 years, proposes a new communication tool to healthcare professionals and their patients.
These websites in Czech and Slovak language presents Stallergenes' activity and the treatment by desensitisation of allergy-related respiratory diseases.
Among the Stallergenes' subsidiaries, 8 have their own website in their language.
For more information, please click here :
www.stallergenes.cz www.stallergenes.sk